Clinical Trial: Sudden Hearing Loss Multi-center Clinical Trial
Study Status: Suspended
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Glucocorticoid Postauricular Injection Treatment for Sudden Hearing Loss: a Multi-center, Opened, Randomized, Controlled Clinical Trial
Brief Summary: The incidence of sudden hearing loss is rising obviously resent year, Glucocorticoids have obtained obvious effect in the treatment of sudden deafness. Postauricular hypodermic injection is the latest findings in clinical work and a new noninvasive way of administration which is gradually expanding research. The aim of this experiment is to verify and explore the efficacy and safety of the postauricular injection treatment with different doses of Glucocorticoids.
Detailed Summary:
Sponsor: Peking University People's Hospital
Current Primary Outcome: Pure tone audiometry test [ Time Frame: Days 30 ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Tinnitus with Evaluation questionnaire [ Time Frame: days 14,30,90 ]Average change in hearing loss in dB between the baseline and D 14, 90 for the three contiguous frequencies with the worst hearing loss; the treatment efficiency of the D 14,90; the treatment efficiency of the tinnitus in D14, 30, 90.
- Vertigo with Evaluation questionnaire [ Time Frame: Day 14,30,90 ]Average change in hearing loss in dB between the baseline and D 14, 90 for the three contiguous frequencies with the worst hearing loss; the treatment efficiency of the D 14,90; the treatment efficiency of the vertigo in D14, 30, 90.
Original Secondary Outcome: Same as current
Information By: Peking University People's Hospital
Dates:
Date Received: December 29, 2013
Date Started: January 2014
Date Completion: December 2016
Last Updated: December 31, 2013
Last Verified: December 2013
